全身内皮功能障碍：新冠病毒病、心血管疾病和代谢性疾病的共同途径。 - Suppr

Suppr

超能文献

Systemic endothelial dysfunction: A common pathway for COVID-19, cardiovascular and metabolic diseases.

作者信息

De Lorenzo Andrea, Escobar Silas, Tibiriçá Eduardo

机构信息

Instituto Nacional de Cardiologia, Rio de Janeiro, RJ, Brazil.

出版信息

Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1401-1402. doi: 10.1016/j.numecd.2020.05.007. Epub 2020 May 18.

DOI:10.1016/j.numecd.2020.05.007

PMID:32425360

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7233254/

Abstract

摘要

相似文献

Systemic endothelial dysfunction: A common pathway for COVID-19, cardiovascular and metabolic diseases.

Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1401-1402. doi: 10.1016/j.numecd.2020.05.007. Epub 2020 May 18.

[Cardiovascular system and COVID-19].

Turk Kardiyol Dern Ars. 2020 Oct;48(7):635-639. doi: 10.5543/tkda.2020.65204.

Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.

JAMA Cardiol. 2020 Jul 1;5(7):751-753. doi: 10.1001/jamacardio.2020.1105.

Statin therapy in COVID-19 infection.

Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):258-259. doi: 10.1093/ehjcvp/pvaa042.

Coronavirus disease 2019 (COVID-19) and acute cardiovascular disease management: A Chinese perspective on striking the balance.

Resuscitation. 2020 Jul;152:36-38. doi: 10.1016/j.resuscitation.2020.05.010. Epub 2020 May 19.

COVID-19: (mis)managing an announced Black Swan.

Eur Heart J. 2020 May 14;41(19):1779-1782. doi: 10.1093/eurheartj/ehaa435.

Commentary: What is the relationship between Covid-19 and cardiovascular disease?

Int J Cardiol. 2020 Jul 1;310:167-168. doi: 10.1016/j.ijcard.2020.03.074. Epub 2020 Mar 31.

Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.

Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):527-528. doi: 10.1016/j.pcad.2020.05.001. Epub 2020 May 7.

Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment.

Heart. 2020 Aug;106(15):1119-1121. doi: 10.1136/heartjnl-2020-317110. Epub 2020 May 25.

The New Normal as Life Goes on Under COVID-19.

Semin Cardiothorac Vasc Anesth. 2020 Dec;24(4):283-286. doi: 10.1177/1089253220969248.

引用本文的文献

Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health.

Geroscience. 2025 Feb;47(1):745-779. doi: 10.1007/s11357-024-01487-4. Epub 2025 Jan 7.

Role of endothelial cells and angiotensin converting enzyme-II in COVID-19 and brain damages post-infection.

Front Neurol. 2023 Jun 30;14:1210194. doi: 10.3389/fneur.2023.1210194. eCollection 2023.

Cerebral small vessel disease pathology in COVID-19 patients: A systematic review.

Ageing Res Rev. 2023 Jul;88:101962. doi: 10.1016/j.arr.2023.101962. Epub 2023 May 22.

Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review.

Cardiovasc Drugs Ther. 2024 Oct;38(5):1017-1032. doi: 10.1007/s10557-023-07465-w. Epub 2023 May 20.

Pathophysiological mechanisms of thrombosis in acute and long COVID-19.

Front Immunol. 2022 Nov 16;13:992384. doi: 10.3389/fimmu.2022.992384. eCollection 2022.

Endothelial dysfunction assessed by brachial artery flow-mediated dilatation predicts severe COVID-19-related disease.

J Family Med Prim Care. 2022 Jan;11(1):319-324. doi: 10.4103/jfmpc.jfmpc_281_21. Epub 2022 Jan 31.

Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19.

Mayo Clin Proc. 2021 Dec;96(12):3099-3108. doi: 10.1016/j.mayocp.2021.06.027. Epub 2021 Aug 19.

The Role of Endothelium in COVID-19.

Int J Mol Sci. 2021 Nov 3;22(21):11920. doi: 10.3390/ijms222111920.

Alterations of Lipid Profile in COVID-19: A Narrative Review.

Curr Probl Cardiol. 2022 Mar;47(3):100907. doi: 10.1016/j.cpcardiol.2021.100907. Epub 2021 May 28.

J Inflamm Res. 2021 May 27;14:2267-2276. doi: 10.2147/JIR.S282710. eCollection 2021.

本文引用的文献

A close-up on COVID-19 and cardiovascular diseases.

Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1057-1060. doi: 10.1016/j.numecd.2020.04.001. Epub 2020 Apr 8.

Endothelial cell infection and endotheliitis in COVID-19.

Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19.

J Thromb Haemost. 2020 Jun;18(6):1517-1519. doi: 10.1111/jth.14844.

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.

Mechanisms of endothelial dysfunction in obesity-associated hypertension.

Braz J Med Biol Res. 2012 May;45(5):392-400. doi: 10.1590/s0100-879x2012007500058. Epub 2012 Apr 12.

Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance.

Circulation. 2004 Jun 1;109(21):2529-35. doi: 10.1161/01.CIR.0000129772.26647.6F. Epub 2004 May 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Systemic endothelial dysfunction: A common pathway for COVID-19, cardiovascular and metabolic diseases.

Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1401-1402. doi: 10.1016/j.numecd.2020.05.007. Epub 2020 May 18.

[Cardiovascular system and COVID-19].

Turk Kardiyol Dern Ars. 2020 Oct;48(7):635-639. doi: 10.5543/tkda.2020.65204.

Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.

JAMA Cardiol. 2020 Jul 1;5(7):751-753. doi: 10.1001/jamacardio.2020.1105.

Statin therapy in COVID-19 infection.

Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):258-259. doi: 10.1093/ehjcvp/pvaa042.

Coronavirus disease 2019 (COVID-19) and acute cardiovascular disease management: A Chinese perspective on striking the balance.

Resuscitation. 2020 Jul;152:36-38. doi: 10.1016/j.resuscitation.2020.05.010. Epub 2020 May 19.

COVID-19: (mis)managing an announced Black Swan.

Eur Heart J. 2020 May 14;41(19):1779-1782. doi: 10.1093/eurheartj/ehaa435.

Commentary: What is the relationship between Covid-19 and cardiovascular disease?

Int J Cardiol. 2020 Jul 1;310:167-168. doi: 10.1016/j.ijcard.2020.03.074. Epub 2020 Mar 31.

Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.

Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):527-528. doi: 10.1016/j.pcad.2020.05.001. Epub 2020 May 7.

Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment.

Heart. 2020 Aug;106(15):1119-1121. doi: 10.1136/heartjnl-2020-317110. Epub 2020 May 25.

The New Normal as Life Goes on Under COVID-19.

Semin Cardiothorac Vasc Anesth. 2020 Dec;24(4):283-286. doi: 10.1177/1089253220969248.

引用本文的文献

Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health.

Geroscience. 2025 Feb;47(1):745-779. doi: 10.1007/s11357-024-01487-4. Epub 2025 Jan 7.

Role of endothelial cells and angiotensin converting enzyme-II in COVID-19 and brain damages post-infection.

Front Neurol. 2023 Jun 30;14:1210194. doi: 10.3389/fneur.2023.1210194. eCollection 2023.

Cerebral small vessel disease pathology in COVID-19 patients: A systematic review.

Ageing Res Rev. 2023 Jul;88:101962. doi: 10.1016/j.arr.2023.101962. Epub 2023 May 22.

Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review.

Cardiovasc Drugs Ther. 2024 Oct;38(5):1017-1032. doi: 10.1007/s10557-023-07465-w. Epub 2023 May 20.

Pathophysiological mechanisms of thrombosis in acute and long COVID-19.

Front Immunol. 2022 Nov 16;13:992384. doi: 10.3389/fimmu.2022.992384. eCollection 2022.

Endothelial dysfunction assessed by brachial artery flow-mediated dilatation predicts severe COVID-19-related disease.

J Family Med Prim Care. 2022 Jan;11(1):319-324. doi: 10.4103/jfmpc.jfmpc_281_21. Epub 2022 Jan 31.

Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19.

Mayo Clin Proc. 2021 Dec;96(12):3099-3108. doi: 10.1016/j.mayocp.2021.06.027. Epub 2021 Aug 19.

The Role of Endothelium in COVID-19.

Int J Mol Sci. 2021 Nov 3;22(21):11920. doi: 10.3390/ijms222111920.

Alterations of Lipid Profile in COVID-19: A Narrative Review.

Curr Probl Cardiol. 2022 Mar;47(3):100907. doi: 10.1016/j.cpcardiol.2021.100907. Epub 2021 May 28.

J Inflamm Res. 2021 May 27;14:2267-2276. doi: 10.2147/JIR.S282710. eCollection 2021.

本文引用的文献

A close-up on COVID-19 and cardiovascular diseases.

Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1057-1060. doi: 10.1016/j.numecd.2020.04.001. Epub 2020 Apr 8.

Endothelial cell infection and endotheliitis in COVID-19.

Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19.

J Thromb Haemost. 2020 Jun;18(6):1517-1519. doi: 10.1111/jth.14844.

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.

Mechanisms of endothelial dysfunction in obesity-associated hypertension.

Braz J Med Biol Res. 2012 May;45(5):392-400. doi: 10.1590/s0100-879x2012007500058. Epub 2012 Apr 12.

Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance.

Circulation. 2004 Jun 1;109(21):2529-35. doi: 10.1161/01.CIR.0000129772.26647.6F. Epub 2004 May 10.